Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NEOGENOMICS, INC.

(NEO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about NEOGENOMICS, INC.
10/19NEOGENOMICS : Subsidiary Enters Into Clinical Trial Collaboration With Princess Margaret C..
MT
10/19NEOGENOMICS' : Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Prin..
PU
10/14Health Care Stocks Moderate Slightly in Afternoon Trading
MT
10/14NEOGENOMICS : Shares Rise After Raymond James Upgrade
MT
10/14Health Care Stocks Keeping Pace With Rising Thursday Markets
MT
10/14NEOGENOMICS : Raymond James Upgrades NeoGenomics to Outperform from Market Perform, Sets $..
MT
10/13NEOGENOMICS : Schedules its Third Quarter 2021, Earnings Release for November 4, 2021
PU
10/12NEOGENOMICS : Appoints Lead Independent Director Lynn Tetrault as Non-Executive Chair. Dou..
PU
10/12NEOGENOMICS INC : Change in Directors or Principal Officers, Financial Statements and Exhi..
AQ
10/12NeoGenomics, Inc. Announces Board Changes
CI
10/12NEOGENOMICS : Announces Board of Directors' Transition
PU
10/01Health Care Stocks Broadly Higher Late Friday
MT
10/01Guardant Health Reportedly Exploring an Acquisition of NeoGenomics
CI
10/01MARKET CHATTER : Guardant Health's Shares Sink on Reports of NeoGenomics Takeover Plans; S..
MT
10/01GUARDANT HEALTH : Reportedly Mulls Acquisition of Diagnostics Services Provider NeoGenomic..
MT
10/01GUARDANT HEALTH SAID TO WEIGH TAKEOV : Bloomberg
MT
09/09NEOGENOMICS' : Liquid Biopsy Subsidiary Inivata and Collaborators to Present Data that Fur..
PU
09/01NEOGENOMICS : to Participate in the Morgan Stanley 19th Annual Global Healthcare Conferenc..
PU
08/26NEOGENOMICS : Benchmark Capital Adjusts NeoGenomics' Price Target to $50 From $46, Maintai..
MT
08/13INSIDER TRENDS : NeoGenomics Insider Sells for Tax Adds to 90-Day Selling Trend
MT
08/10NEOGENOMICS INC : Regulation FD Disclosure (form 8-K)
AQ
08/09NEOGENOMICS : Morgan Stanley Adjusts Price Target on NeoGenomics to $58 From $64, Maintain..
MT
08/06NEOGENOMICS : Q2 Earnings Snapshot
AQ
08/06NEOGENOMICS : Q2 Net Loss Narrows, Revenue Rises, Reiterates Guidance; Shares Edge Higher ..
MT
08/06NeoGenomics Seeks M&A
CI
08/06NEOGENOMICS INC : Results of Operations and Financial Condition (form 8-K)
AQ
08/06NeoGenomics, Inc. Reiterates Consolidated Earnings Guidance for the Year 2021
CI
08/06NEOGENOMICS : Earnings Flash (NEO) NEOGENOMICS Reports Q2 Loss $-0.01
MT
08/06NEOGENOMICS : Earnings Flash (NEO) NEOGENOMICS Reports Q2 Revenue $121.7M
MT
08/06GUIDANCE : (NEO) NEOGENOMICS Forecasts Fiscal Year 2021 Revenue Range $490M - $510M
MT
08/06NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
07/14NEOGENOMICS : Schedules its Second Quarter 2021 Earnings Release for August 6, 2021
PU
07/07NEOGENOMICS INC : Change in Directors or Principal Officers (form 8-K)
AQ
07/07NeoGenomics, Inc. Appoints George A. Cardoza as President and Chief Operating Officer, ..
CI
06/24NEOGENOMICS INC : Completion of Acquisition or Disposition of Assets (form 8-K)
AQ
06/24NeoGenomics, Inc. Announces Appointment of Clive Morris as President
CI
06/24NEOGENOMICS : Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Techno..
PU
06/18NEOGENOMICS : Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Techno..
PU
06/08NEOGENOMICS INC : Other Events (form 8-K)
AQ
06/07NEOGENOMICS : Insider Makes Significant Stock Sells in NeoGenomics (NEO) Shares
MT
06/04INSIDER TRENDS : NeoGenomics Insider Extends 90-Day Selling Trend
MT
06/03NEOGENOMICS : Goldman Sachs Starts NeoGenomics at Buy With $55 Price Target
MT
06/01NEOGENOMICS INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/27NEOGENOMICS : To Participate Virtually In Multiple Upcoming Institutional Investor Confere..
PU
05/25NEOGENOMICS : Truist Securities Adjusts NeoGenomics' Price Target to $54 From $65, Maintai..
MT
05/10NEOGENOMICS : To Participate In The Bank of America 2021 Health Care Conference
PU
05/06NEOGENOMICS INC : Regulation FD Disclosure (form 8-K)
AQ
05/06NEOGENOMICS : Needham Adjusts NeoGenomics' Price Target to $55 From $65; Buy Rating Kept
MT
05/05NEOGENOMICS : Q1 Earnings Snapshot
AQ
05/05NEOGENOMICS : Investor Presentation – May 2021
PU
05/05NEOGENOMICS : Inivata Special Presentation
PU
05/05NEOGENOMICS : Conference Call Presentation
PU
05/05NEOGENOMICS' : Q1 Loss Widens, Revenue Rises
MT
05/05NEOGENOMICS : Management Change/Compensation
PU
05/05NEOGENOMICS INC : Change in Directors or Principal Officers (form 8-K)
AQ
05/05NEOGENOMICS INC : Results of Operations and Financial Condition (form 8-K)
AQ
05/05NEOGENOMICS INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity ..
AQ
05/05NEOGENOMICS : Establishes NeoGenomics as a technology leader in the minimal residual disea..
PU
05/05NEOGENOMICS INC : Entry into a Material Definitive Agreement, Financial Statements and Exh..
AQ
05/05NEOGENOMICS : Reports 9% Revenue Growth to $116 Million in the First Quarter
PU
05/05NEOGENOMICS : Earnings Flash (NEO) NEOGENOMICS Posts Q1 Revenue $115.5M
MT
05/05NEOGENOMICS : Earnings Flash (NEO) NEOGENOMICS Posts Q1 Loss $-0.04
MT
05/05GUIDANCE : (NEO) NEOGENOMICS Sees Fiscal Year 2021 Revenue Range $490M - $510M
MT
05/05NeoGenomics Seeks Acquisitions
CI
05/05NeoGenomics, Inc. Provides Consolidated Earnings Guidance for the Year 2021
CI
05/05NeoGenomics, Inc. Announces Resignation of Lawrence M. Weiss as Chief Medical Officer
CI
05/05Neogenomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
05/05IP Group to Receive $91 Million from Sale of Portfolio Company Inivata
MT
05/05NEOGENOMICS : Exercises Option to Acquire Remaining Stake in Cambridge-Based Inivata for $..
MT
05/05NEOGENOMICS : to Acquire Inivata - Combining Best-In-Class Liquid Biopsy Technology with L..
PU
04/26INSIDER TRENDS : NeoGenomics Insider Exercises Options Extending 90-Day Buying Trend
MT
04/21NEOGENOMICS : Initial Insider Trading Report (SEC Filing - 3)
PU
04/19NEOGENOMICS : Announces the Launch of Biomarker Assist KRAS Single Gene Testing (SGT) Prog..
PU
04/15NEOGENOMICS INC : Change in Directors or Principal Officers (form 8-K)
AQ
04/15NEOGENOMICS INC : Other Events (form 8-K)
AQ
1  2  3  4Next
Upcoming event on NEOGENOMICS, INC.